DarioHealth
DRIO
14 hedge funds and large institutions have $2.61M invested in DarioHealth in 2020 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
21% more capital invested
Capital invested by funds: $2.16M → $2.61M (+$450K)
17% more funds holding
Funds holding: 12 → 14 (+2)
0.03% more ownership
Funds ownership: 0.51% → 0.54% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$397K |
| 2 |
Renaissance Technologies
New York
|
+$114K |
| 3 |
IIA
IPG Investment Advisors
San Diego,
California
|
+$52.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$19K |
| 5 |
Goldman Sachs
New York
|
+$14.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$3K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.33K |
DRIO Hedge Fund Activity: Q2 2020 in Review
14 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2020, worth a combined $2.61M — up 21% from $2.16M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new DRIO positions and 2 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Meitav Investment House, adding an estimated $397K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $3K sold.
- 14 institutional investors held DarioHealth (DRIO) as of Q2 2020, up from 12 in Q1 2020.
- Funds reported $2.61M of DarioHealth stock for Q2 2020, up 21% quarter-over-quarter.
- 4 funds opened new DarioHealth positions in Q2 2020 and 2 closed out, a net change of +2 holders.
- The largest DarioHealth buyer in Q2 2020 was Meitav Investment House, an estimated $397K added.
- The largest DarioHealth seller in Q2 2020 was JP Morgan Chase, an estimated $3K sold.
Based on aggregated 13F filings for Q2 2020.